By CAPosts 26 February, 2021 - 04:26pm 106 views
A committee of experts unanimously recommended the emergency authorization in the United States of Johnson & Johnson's single-dose covid-19 vaccine for people over 18 years of age, with which the country is about to have one more option easy to use to fight the pandemic
© Provided by Millennium Johnson & Johnson claims to be able to produce 20 million vaccines for the U.S.
The opinion of this committee, composed mainly of independent scientists, is advisory, but an indicator of the probable authorization of the vaccine by the US health authorities.
The members of the committee that evaluates vaccines at the FDA unanimously considered that the benefits of the vaccine outweigh the risks for the elderly , so that, once its approval is confirmed, it may be added as the third vaccine against the Covid-19 available to Americans
The Food and Drug Administration (FDA) is expected to quickly respond to the recommendation and make the J&J inoculation the third to be authorized for emergency use in the United States United.
The vaccination campaign is progressing with increasing agility, but new supplies are urgently needed to keep ahead of a mutant virus that has killed more than 500,000 Americans.